Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

The chimeric cytokine Hyper-IL-6 enhances the efficiency of lentiviral gene transfer in hepatocytes both in vitro and in vivo (2008)

  • Authors:
  • USP affiliated authors: COVAS, DIMAS TADEU - FMRP
  • USP Schools: FMRP
  • DOI: 10.1007/s10529-007-9528-x
  • Subjects: GENES (TERAPIA); LENTIVIRUS; FÍGADO; TRANSFERÊNCIA DE GENES
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s10529-007-9528-x (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Biotechnology Letters

    ISSN: 0141-5492

    Citescore - 2017: 1.88

    SJR - 2017: 0.621

    SNIP - 2017: 0.695


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP11200051310-Spcd 1639990
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PICANÇO-CASTRO, Virgínia; FONTES, Aparecida Maria; HEINZ, Stefan; TONN, Torsten; COVAS, Dimas Tadeu. The chimeric cytokine Hyper-IL-6 enhances the efficiency of lentiviral gene transfer in hepatocytes both in vitro and in vivo. Biothecnology Letters, New York, v. 30, n. 2, p. 215-220, 2008. DOI: 10.1007/s10529-007-9528-x.
    • APA

      Picanço-Castro, V., Fontes, A. M., Heinz, S., Tonn, T., & Covas, D. T. (2008). The chimeric cytokine Hyper-IL-6 enhances the efficiency of lentiviral gene transfer in hepatocytes both in vitro and in vivo. Biothecnology Letters, 30( 2), 215-220. doi:10.1007/s10529-007-9528-x
    • NLM

      Picanço-Castro V, Fontes AM, Heinz S, Tonn T, Covas DT. The chimeric cytokine Hyper-IL-6 enhances the efficiency of lentiviral gene transfer in hepatocytes both in vitro and in vivo. Biothecnology Letters. 2008 ; 30( 2): 215-220.
    • Vancouver

      Picanço-Castro V, Fontes AM, Heinz S, Tonn T, Covas DT. The chimeric cytokine Hyper-IL-6 enhances the efficiency of lentiviral gene transfer in hepatocytes both in vitro and in vivo. Biothecnology Letters. 2008 ; 30( 2): 215-220.

    Referências citadas na obra
    Beck M (2007) New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Hum Genet 121:1–22
    Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C, Grez M, Thrasher AJ (2002) High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 13:803–813
    Emerman M (2000) Learning from lentiviruses. Nat Genet 24:8–9
    Fischer M, Goldschmitt J, Peschel C, Brakenhoff JP, Kallen KJ, Wollmer A, Grotzinger J, Rose-John S (1997) I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 15:142–145
    Follenzi A, Battaglia M, Lombardo A, Annoni A, Roncarolo MG, Naldini L (2004) Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 103:3700–3709
    Follenzi A, Naldini L (2002a) Generation of HIV-1 derived lentiviral vectors. Methods Enzymol 346:454–465
    Follenzi A, Naldini L (2002b) HIV-based vectors. Preparation and use. Methods Mol Med 69:259–274
    Hecht N, Pappo O, Shouval D, Rose-John S, Galun E, Axelrod JH (2001) Hyper-IL-6 gene therapy reverses fulminant hepatic failure. Mol Ther 3:683–687
    Henry RJ, Chiamori N, Golub OJ, Berkman S (1960) Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol 34:381–398
    Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM (1997) Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17:314–317
    Kaleko M, Garcia JV, Miller AD (1991) Persistent gene expression after retroviral gene transfer into liver cells in vivo. Hum Gene Ther 2:27–32
    Kalsheker N, Morley S, Morgan K (2002) Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans 30:93–98
    Kay MA, Glorioso JC, Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7:33–40
    Kitten O, Cosset FL, Ferry N (1997) Highly efficient retrovirus-mediated gene transfer into rat hepatocytes in vivo. Hum Gene Ther 8:1491–1494
    Korin YD, Zack JA (1998) Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol 74:3161–3168
    Mastromarino P, Conti C, Goldoni P, Hauttecoeur B, Orsi N (1987) Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J Gen Virol 68:2359–2369
    McGlynn LK, Mueller CR, Begbie M, Notley CR, Lillicrap D (1996) Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor V111 gene. Mol Cell Biol 16:1936–1945
    Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239–4242
    Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE (1999) Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283:682–686
    Nakai H, Herzog RW, Hagstrom JN, Walter J, Kung SH, Yang EY, Tai SJ, Iwaki Y, Kurtzman GJ, Fisher KJ, others (1998) Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 91:4600–4607
    Naldini L, Blomer U, Gage FH, Trono D, Verma IM (1996a) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93:11382–11388
    Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996b) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263–267
    Ohashi K, Park F, Kay MA (2002) Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo. Hum Gene Ther 13:653–663
    Park F, Ohashi K, Chiu W, Naldini L, Kay MA (2000) Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet 24:49–52
    Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S (1998) Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18:180–183
    Schmitz V, Qian C, Ruiz J, Sangro B, Melero I, Mazzolini G, Narvaiza I, Prieto J (2002) Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies. Gut 50:130–135
    Selden C, Mellor N, Rees M, Laurson J, Kirwan M, Escors D, Collins M, Hodgson H (2007) Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytes. J Gene Med 9:67–76
    Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, others (1997) Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 16:270–276
    Sutton RE, Reitsma MJ, Uchida N, Brown PO (1999) Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J Virol 73:3649–3660
    Yao SN, Farjo A, Roessler BJ, Davidson BL, Kurachi K (1996) Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver. Viral Immunol 9:141–153
    Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871–875